INS and breast carcinoma: Numerous prospective cohort studies have indeed reported that elevated levels of fasting insulin or C‐peptide, a marker for insulin secretion, were associated with higher breast cancer incidence6, 7, 8, 9, 10 and experimental studies have shown that insulin may lead to breast cancer development through its mitogenic and antiapoptotic activity.11, 12